Tianjin Medical University Cancer Institute and Hospital
The birthplace of Chinese oncology (an 1861 mission hospital, made a cancer hospital in 1952 under Jin Xianzhai) and a national centre for breast and pancreatic cancer.
TMUCIH traces its origins to 1861 and became China's first specialised cancer hospital in 1952 under Jin Xianzhai, the founder of Chinese oncology. It is a national clinical research centre for cancer, hosts the Key Laboratory of Cancer Prevention and Therapy, and runs one of China's largest breast cancer programmes alongside strong pancreatic, lung, head and neck and gynaecological services. Its epidemiology group produces long-running cancer incidence data for Tianjin, and the hospital has been an early adopter of intraoperative radiotherapy, tomotherapy and robotic surgery. It is a frequent lead site for Chinese breast and pancreatic trials.
- Breast cancer
- Pancreatic cancer
- Cancer epidemiology
- Radiotherapy technology
Pages like this
not linked directly; found by shared links- IdeaOne-stop breast clinics: imaging, biopsy and a preliminary answer in a single visit
Shares Mammography & tomosynthesis, HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- InstitutionSiriraj Hospital, Mahidol University
Shares Robotic & minimally invasive surgery, IMRT / IGRT (modern external beam), Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer.
- InstitutionUniversity of Malaya Medical Centre
Shares IMRT / IGRT (modern external beam), Head and neck squamous cell carcinoma, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- InstitutionFundación Arturo López Pérez
Shares Intraoperative radiotherapy (IORT), Robotic & minimally invasive surgery, HR-positive / HER2-negative breast cancer.
- CollectionSusan G. Komen
Shares Mammography & tomosynthesis, HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- InstitutionRajiv Gandhi Cancer Institute and Research Centre
Shares Robotic & minimally invasive surgery, IMRT / IGRT (modern external beam), Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer.
- PersonLaura J. Esserman
Shares Mammography & tomosynthesis, HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- TechnologyMirai (MIT breast cancer risk from mammograms)
Shares Mammography & tomosynthesis, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.